Accès ouvert déclaré
2015
article
Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci.
Kyle J. Gaulton, Teresa Ferreira, Yeji Lee, Anne Raimondo, Michael E. Reschen, Anubha Mahajan, Adam E. Locke, N. William Rayner, Neil Robertson, Robert A. Scott, Inga Prokopenko, Laura J. Scott, Todd J. Green, Thomas Sparsø, Dorothée Thuillier, Loic Yengo, Harald Grallert, Simone Wahl, Mattias Frånberg, Rona J. Strawbridge, Hans A. Kestler, Himanshu Chheda, Lewin Eisele, Stefan Gustafsson, Valgerður Steinthórsdóttir, Guðmar Þorleifsson, Lu Qi, Lennart C. Karssen, Sara M. Willems, Man Li, Han Chen, Christian Fuchsberger, Phoenix Kwan, Clement Ma, Michael D. Linderman, Yingchang Lu, Soren K. Thomsen, Jana K. Rundle, Nicola L. Beer, Martijn van de Bunt, Anil Chalisey, Hyun Min Kang, Benjamin F. Voight, Gonçalo R. Abecasis, Peter Almgren, Damiano Baldassarre, Beverley Balkau, Rafn Benediktsson, Heiner Boeing, Lori L. Bonnycastle, Erwin P. Böttinger, Noël P. Burtt, Jason Carey, G. Charpentier, Peter S. Chines, Marilyn C. Cornelis, David Couper, Andrew Crenshaw, Rob M. van Dam, Alex S. F. Doney, Mozhgan Dorkhan, Sarah Edkins, Johan G. Eriksson, Tõnu Esko, Elodie Eury, João Fadista, Jason Flannick, Pierre Fontanillas, Caroline S. Fox, Paul W. Franks, Karl Gertow, Christian Gieger, Bruna Gigante, Omri Gottesman, George Grant, Niels Grarup, Christopher J. Groves, Maija Hassinen, Christian Herder, Oddgeir L. Holmen, Ástráður B. Hreiðarsson, Steve E. Humphries, Sarah Hunt, Anne Jackson, Anna Jonsson, Marit E. Jørgensen, Torben Jørgensen, Wen‐Hong L. Kao, Nicola D. Kerrison, Leena Kinnunen, Norman Klopp, Augustine Kong, Péter Kovács, Peter Kraft, Jasmina Kravić, Cordelia Langford, Karin Leander, Liming Liang, Peter Lichtner, Cecilia M. Lindgren, Eero Lindholm, Allan Linneberg, Ching‐Ti Liu, Stéphane Lobbens, Jian’an Luan, Valeriya Lyssenko, Satu Männistö, Olga McLeod, Julia Meyer, Evelin Mihailov, Ghazala Mirza, Thomas W. Muehleisen, Martina Müller‐Nurasyid, Carmen Navarro, Markus M. Nöethen, Nikolay Oskolkov, Katharine R. Owen, Domenico Palli, Sonali Pechlivanis, Leena Peltonen, John R. B. Perry, Carl G. P. Platou, Michael Roden, Douglas M. Ruderfer, Denis Rybin, Yvonne T. van der Schouw, Bengt Sennblad, Gunnar Sigurðsson, Alena Stančáková, Gerald Steinbach, Petter Storm, Konstantin Strauch, Heather M. Stringham, Qi Sun, Barbara Thorand, Emmi Tikkanen, Anke Tönjes, Joseph Trakalo, Elena Tremoli, Roman Wennauer, Steven Wiltshire, Andrew R. Wood, Eleftheria Zeggini, Ian Dunham, Ewan Birney, Lorenzo Pasquali, Jorge Ferrer, Ruth J. F. Loos, Josée Dupuis, José C. Florez, Eric Boerwinkle, James S. Pankow, Cornelia M. van Duijn, Eric J.G. Sijbrands, James B. Meigs, Frank B. Hu, Unnur Þorsteinsdóttir, Kāri Stefánsson, Timo A. Lakka, Rainer Rauramaa, Michael Stümvoll, Nancy L. Pedersen, Lars Lind, Sirkka Keinänen‐Kiukaanniemi, Eeva Korpi-Hyövälti, Timo Saaristo, Juha Saltevo, Johanna Kuusisto, Markku Laakso, Andres Metspalu, Raimund Erbel, Susanne Moebus, Samuli Ripatti, Veikko Salomaa, Erik Ingelsson, Bernhard O. Boehm, Richard N. Bergman, Francis S. Collins, Karen L. Mohlke, Heikki A. Koistinen, Jaakko Tuomilehto, Kristian Hveem, Inger Njølstad, Peter Donnelly, Timothy M. Frayling, Andrew T. Hattersley, Ulf dé Fairé, Anders Hamsten, Thomas Illig, Annette Peters, Stéphane Cauchi, Robert Sladek, Philippe Froguel, Torben Hansen, Oluf Pedersen, Andrew D. Morris, Collin N. A. Palmer, Sekar Kathiresan, Olle Melander, Peter M. Nilsson, Leif Groop, Inês Barroso, Claudia Langenberg, Nicholas J. Wareham, Christopher A. O’Callaghan, Anna L. Gloyn, David Altshuler, Michael Boehnke, Tanya M. Teslovich, Mark I. McCarthy, Andrew P. Morris
0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés
Le résumé fourni par la source
We performed fine mapping of 39 established type 2 diabetes (T2D) loci in 27,206 cases and 57,574 controls of European ancestry. We identified 49 distinct association signals at these loci, including five mapping in or near KCNQ1. 'Credible sets' of the variants most likely to drive each distinct signal mapped predominantly to noncoding sequence, implying that association with T2D is mediated through gene regulation. Credible set variants were enriched for overlap with FOXA2 chromatin immunoprecipitation binding sites in human islet and liver cells, including at MTNR1B, where fine mapping implicated rs10830963 as driving T2D association. We confirmed that the T2D risk allele for this SNP increases FOXA2-bound enhancer activity in islet- and liver-derived cells. We observed allele-specific differences in NEUROD1 binding in islet-derived cells, consistent with evidence that the T2D risk allele increases islet MTNR1B expression. Our study demonstrates how integration of genetic and genomic information can define molecular mechanisms through which variants underlying association signals exert their effects on disease.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
La source scientifique ouverte est momentanément indisponible.
Les sujets associés
Bioinformatics and Genomic NetworksGenetic Associations and EpidemiologyMachine Learning in Bioinformatics